Myovant Sciences Ltd.

(NYSE:myov) Trade

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Myovant Sciences Ltd is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its product candidate is relugolix.

Contact Information

Website: www.myovant.com
Email: investors@myovant.com
Main Phone: +44 2033189709
Address: 11-12 St. James's Square
Address 2: Suite 1, 3rd Floor
City / Town: London
Country: GBR
Postal Code: SW1Y 4LB

Issuer Information

Exchange: NYE
CEO: Lynn Seely
Employees: 104
Issuer Type: CS - Common Stock
Sector/Industry: Healthcare

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A